|
|
Volumn 4, Issue 1, 2003, Pages 55-75
|
|
National Institutes of Health Consensus Development Conference Statement Management of Hepatitis C: 2002 June 10-12, 2002
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ANTIDEPRESSANT AGENT;
ANTIVIRUS AGENT;
HEMOPOIETIC GROWTH FACTOR;
HEPATITIS A VACCINE;
HEPATITIS B VACCINE;
PEGINTERFERON ALPHA2A;
PEGINTERFERON ALPHA2B;
RIBAVIRIN;
SEROTONIN UPTAKE INHIBITOR;
VIRUS ANTIBODY;
VIRUS ANTIGEN;
VIRUS RNA;
ALCOHOL CONSUMPTION;
BLOOD TOXICITY;
BRANCHED DNA SIGNAL AMPLIFICATION ASSAY;
CLINICAL FEATURE;
CLINICAL RESEARCH;
CLINICAL TRIAL;
CONFERENCE PAPER;
CYTOPENIA;
DEPRESSION;
DIAGNOSTIC VALUE;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG USE;
ENZYME IMMUNOASSAY;
EPIDEMIOLOGICAL DATA;
FLU LIKE SYNDROME;
FUTUROLOGY;
GENETIC HETEROGENEITY;
HEALTH CARE ORGANIZATION;
HEALTH SURVEY;
HEMOLYSIS;
HEPATITIS C;
HEPATITIS C VIRUS;
HIGH RISK PATIENT;
HUMAN;
INFECTION RISK;
LIVER BIOPSY;
LIVER CELL CARCINOMA;
LIVER CIRRHOSIS;
LIVER TRANSPLANTATION;
MONOTHERAPY;
PATHOGENESIS;
PATIENT COMPLIANCE;
PATIENT EDUCATION;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
PSYCHOPATHY;
RECURRENT DISEASE;
SCREENING TEST;
SENSITIVITY AND SPECIFICITY;
VIRUS TRANSMISSION;
|
|
EID: 0037229595
PISSN: 15284336
EISSN: None
Source Type: Journal
DOI: 10.1310/86XW-Y6PX-TNE7-YM7J Document Type: Conference Paper |
|
Times cited : (11)
|
|
References (0)
|